Treatment Planning Systems and Advanced Image Processing Market Trends
Market participants are increasingly adopting artificial intelligence and machine learning to develop oncology software solutions, thereby enhancing treatment plans, diagnoses, and overall cancer management.
Additionally, various initiatives and projects are being undertaken to create health information learning platforms aimed at improving the quality of oncology care. These efforts are anticipated to further drive market growth.
For instance, in December 2023, ConcertAI announced the acquisition of CancerLinQ, an innovative oncology learning health system that had previously been a subsidiary of the American Society of Clinical Oncology (ASCO). In conjunction with this acquisition, ASCO entered into a multi-year collaboration agreement with CancerLinQ. This new partnership aimed to enhance and expand the utilization of real-world data, analytics, next-generation artificial intelligence, and other technologies to improve cancer care and expedite clinical research.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The treatment planning systems and advanced image processing market size was valued at USD 2 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032 due to the rising prevalence of cancer.
The oncology segment in the market generated USD 994.8 million in 2023 and is expected to grow at 8.8% CAGR during 2024-2032 owing to the ongoing innovations in imaging technologies.
North America treatment planning systems and advanced image processing market will reach USD 1.9 billion by 2032 due to the well-established healthcare infrastructure.
Accuray Incorporated, Agfa-Gevaert Group, Brainlab AG, Canon Medical Systems Corporation, C-RAD AB, Elekta AB, GE HealthCare Technologies Inc., Hitachi, Ltd., IBA Radiopharma Solutions, IntraOp Medical Corporation, and Koninklijke Philips N.V among others
Treatment Planning Systems and Advanced Image Processing Market Scope